Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Ishen, Seocharan"'
Autor:
Ameena Goga, Trisha Ramraj, Logashvari Naidoo, Brodie Daniels, Masefetsane Matlou, Terusha Chetty, Reshmi Dassaye, Nobubelo K. Ngandu, Laura Galli, Tarylee Reddy, Ishen Seocharan, Qondeni Ndlangamandla, Qholokazi September, Nokwanda Ngcobo, Mayuri Reddy, Tamon Cafun-Naidoo, Kubashni Woeber, Nitesha Jeenarain, Rabia Imamdin, Keshnee Maharajh, Ashmintha Ramjeth, Thobile Bhengu, Emma Clarence, Philippe Van de Perre, Thorkild Tylleskär, Nicolas Nagot, Jean-Pierre Moles, Penny L. Moore, Nonhlanhla N. Mkhize, Lucio Gama, Stefania Dispinseri, Priscilla Biswas, Gabriella Scarlatti, the PedMAb1 clinical trial team
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background The ambitious goal to eliminate new pediatric HIV infections by 2030 requires accelerated prevention strategies in high-risk settings such as South Africa. One approach could be pre-exposure prophylaxis (PrEP) with broadly neutral
Externí odkaz:
https://doaj.org/article/289c4aae8d584a3bb56f8bc46eb6cc68
Autor:
Rajendra Maharaj, Ishen Seocharan, Vishan Lakan, Zuziwe Nyawo, Moses Mkhabela, Yusentha Balakrishna
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Background The decreasing residual efficacy of insecticides is an important factor when making decisions on insecticide choice for national malaria control programmes. The major challenge to using chemicals for vector control is the selectio
Externí odkaz:
https://doaj.org/article/0bc8499900694229b384f502829cae06
Autor:
Chanel Avenant, Mandisa Singata-Madliki, Alexis J. Bick, Donita Africander, Yusentha Balakrishna, Karl-Heinz Storbeck, Johnson M. Moliki, Sigcinile Dlamini, Salndave Skosana, Jenni Smit, Mags Beksinska, Ivana Beesham, Ishen Seocharan, Joanne Batting, George J. Hofmeyr, Janet P. Hapgood
Publikováno v:
PLoS ONE, Vol 19, Iss 8 (2024)
Externí odkaz:
https://doaj.org/article/8ffaf5cf7d734ba98dfdbbf021c4015b
Autor:
Mandisa Singata-Madliki, Jenni Smit, Mags Beksinska, Yusentha Balakrishna, Chanel Avenant, Ivana Beesham, Ishen Seocharan, Joanne Batting, Janet P Hapgood, G Justus Hofmeyr
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0295764 (2024)
BackgroundObservational data suggest lower HIV risk with norethisterone enanthate (NET-EN) than with depo-medroxyprogesterone acetate intramuscular (DMPA-IM) injectable contraceptives. If confirmed, a switch between these similar injectable methods w
Externí odkaz:
https://doaj.org/article/704d6d4312d6488583bdcf6ab180a1c3
Autor:
Rajendra Maharaj, Abigail Ward, Bradley Didier, Ishen Seocharan, Nina Firas, Ryleen Balawanth, Dominic Lucero, Natashia Morris, Mbavhalelo Shandukani, Eric Raswiswi, Gillian Malatjie, Erik Mabunda, Devanand Moonasar
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-8 (2023)
Abstract Background For a country such as South Africa which is targeting malaria elimination, mobile and migrant populations pose a substantial risk to importation of malaria parasites. It has been hypothesized that halting cross-border movement of
Externí odkaz:
https://doaj.org/article/643200e325f4446d9d1e0ad271ee1485
Autor:
Khatija Ahmed, Mookho Malahleha, Thulisile E. Mbatsane, Dineo Thindisa, Veronique C. Bailey, Ishen Seocharan, Athmanundh Dilraj
Publikováno v:
South African Journal of Science, Vol 119, Iss 7/8 (2023)
In clinical trials, a vital protocol requirement for participants is adherence to scheduled visits. A substantial number of missed visits and the resultant missing data could affect generalisability of the findings and undermine the scientific conclu
Externí odkaz:
https://doaj.org/article/9fbf07c3eca34687a333088094e649d9
Autor:
Linda-Gail Bekker, Glenda Gray, Nigel Garrett, Ameena Goga, Amber Khan, Ishen Seocharan, Ian Sanne, Jonny Peter, Shirley Collie, Nonhlanhla Yende-Zuma, Barry Frank Jacobson, Elise Schapkaitz, Azwi Takalani, Jessica Opie, Tarylee Reddy, Michelle Robinson, Simbarashe Takuva, Pradeep Rowji, Vernon Johan Louw
Publikováno v:
BMJ Medicine, Vol 2, Iss 1 (2023)
Objective To assess the rates of vascular thrombotic adverse events in the first 35 days after one dose of the Ad26.COV2.S vaccine (Janssen/Johnson & Johnson) in healthcare workers in South Africa and to compare these rates with those observed in the
Externí odkaz:
https://doaj.org/article/21279cd2d8d146c39b53664e453fd4e3
Autor:
Simbarashe Takuva, Azwidhwi Takalani, Ishen Seocharan, Nonhlanhla Yende-Zuma, Tarylee Reddy, Imke Engelbrecht, Mark Faesen, Kentse Khuto, Carmen Whyte, Veronique Bailey, Valentina Trivella, Jonathan Peter, Jessica Opie, Vernon Louw, Pradeep Rowji, Barry Jacobson, Pamela Groenewald, Rob E. Dorrington, Ria Laubscher, Debbie Bradshaw, Harry Moultrie, Lara Fairall, Ian Sanne, Linda Gail-Bekker, Glenda Gray, Ameena Goga, Nigel Garrett, Sisonke study team
Publikováno v:
PLoS Medicine, Vol 19, Iss 6 (2022)
Background Real-world evaluation of the safety profile of vaccines after licensure is crucial to accurately characterise safety beyond clinical trials, support continued use, and thereby improve public confidence. The Sisonke study aimed to assess th
Externí odkaz:
https://doaj.org/article/a52f1c61583246039456e4e8941f0bae
Autor:
Rajendra Maharaj, Ishen Seocharan, Bheki Qwabe, Moses Mkhabela, Sunitha Kissoon, Vishan Lakan
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-7 (2019)
Abstract Background Although malaria remains a noteworthy disease in South Africa, the provinces are at differing stages of the malaria elimination continuum. KwaZulu-Natal has consistently reported the lowest number of cases over the past 5 years an
Externí odkaz:
https://doaj.org/article/0bfd362a372c4b628371e69511e6719f
Autor:
Nigel, Garrett, Asa, Tapley, Jessica, Andriesen, Ishen, Seocharan, Leigh H, Fisher, Lisa, Bunts, Nicole, Espy, Carole L, Wallis, April Kaur, Randhawa, Maurine D, Miner, Nzeera, Ketter, Margaret, Yacovone, Ameena, Goga, Yunda, Huang, John, Hural, Philip, Kotze, Linda Gail, Bekker, Glenda E, Gray, Lawrence, Corey, Ian, Sanne
Publikováno v:
Clinical Infectious Diseases. 75:e289-e292
We report a 23% asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) Omicron carriage rate in participants being enrolled into a clinical trial in South Africa, 15-fold higher than in trials before Omicron. We also found lower CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ad2c6f0e27c201e978571103bfb040
https://doi.org/10.1093/cid/ciac237
https://doi.org/10.1093/cid/ciac237